We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Expert Opinion / Cases · November 05, 2018

Recurrent/Metastatic Triple Negative BRCA Positive Breast Cancer

Written by
Sameer Nasir MD


Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Elchin  Mansurov

    For Bilateral MBC, IDC ,G3, TN(ES,Pr,Her2-neqative ) BRCA 1 mut(+) -metastatik (oss/lym) breast cancer all therapy palliative. 1st line palliative therapy-chemotherapy with TP (6 cycls) +zoledronic acid 4mq ( 1year 12 cycls ), concurent or then radiotherapy left femoral head lesion

  • heba  abusin

    weekly taxol or cisplatin single agent

  • puthuveettil jayaprakash


  • Jo Mondani

    ? Olaparib ( OlimpiaD)

  • Sara Altuna

    Olaparib + Zolendronic Acid.

  • Dec 03, 2020

    Pending Moderator approval.

Further Reading